These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 11569948)

  • 1. Apoptosis modulators as cancer therapeutics.
    Penn LZ
    Curr Opin Investig Drugs; 2001 May; 2(5):684-92. PubMed ID: 11569948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular neuro-oncology and the development of targeted therapeutic strategies for brain tumors. Part 5: apoptosis and cell cycle.
    Newton HB
    Expert Rev Anticancer Ther; 2005 Apr; 5(2):355-78. PubMed ID: 15877531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic targeting of apoptosis pathways in cancer.
    Ziegler DS; Kung AL
    Curr Opin Oncol; 2008 Jan; 20(1):97-103. PubMed ID: 18043263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-apoptotic proteins-targets for chemosensitization of tumor cells and cancer treatment.
    Kostanová-Poliaková D; Sabová L
    Neoplasma; 2005; 52(6):441-9. PubMed ID: 16284687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical and clinical development of novel agents that target the protein kinase C family.
    Serova M; Ghoul A; Benhadji KA; Cvitkovic E; Faivre S; Calvo F; Lokiec F; Raymond E
    Semin Oncol; 2006 Aug; 33(4):466-78. PubMed ID: 16890801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis in the development and treatment of cancer.
    Gerl R; Vaux DL
    Carcinogenesis; 2005 Feb; 26(2):263-70. PubMed ID: 15375012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overcoming resistance of cancer cells to apoptosis.
    Hersey P; Zhang XD
    J Cell Physiol; 2003 Jul; 196(1):9-18. PubMed ID: 12767037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Directing cancer cells to self-destruct with pro-apoptotic receptor agonists.
    Ashkenazi A
    Nat Rev Drug Discov; 2008 Dec; 7(12):1001-12. PubMed ID: 18989337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of apoptosis signaling for cancer therapy.
    Fulda S; Debatin KM
    Arch Immunol Ther Exp (Warsz); 2006; 54(3):173-5. PubMed ID: 16652217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors.
    Faivre S; Djelloul S; Raymond E
    Semin Oncol; 2006 Aug; 33(4):407-20. PubMed ID: 16890796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of death receptors--relevance in cancer therapies.
    de Thonel A; Eriksson JE
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):123-32. PubMed ID: 16126242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defects in apoptotic signal transduction in cisplatin-resistant non-small cell lung cancer cells.
    Ikuta K; Takemura K; Kihara M; Naito S; Lee E; Shimizu E; Yamauchi A
    Oncol Rep; 2005 Jun; 13(6):1229-34. PubMed ID: 15870947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers.
    Sabbah M; Emami S; Redeuilh G; Julien S; Prévost G; Zimber A; Ouelaa R; Bracke M; De Wever O; Gespach C
    Drug Resist Updat; 2008; 11(4-5):123-51. PubMed ID: 18718806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting multiple signaling pathways as a strategy for managing prostate cancer: multifocal signal modulation therapy.
    McCarty MF
    Integr Cancer Ther; 2004 Dec; 3(4):349-80. PubMed ID: 15523106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoid targets for apoptosis induction.
    Pfahl M; Piedrafita FJ
    Oncogene; 2003 Dec; 22(56):9058-62. PubMed ID: 14663484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drug resistance mediated by survival- and growth-promoting signaling pathways].
    Fujita N
    Gan To Kagaku Ryoho; 2009 Apr; 36(4):567-71. PubMed ID: 19381028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones.
    Workman P
    Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S45-56. PubMed ID: 12819933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fundamental principals of tumor necrosis factor-alpha gene therapy approach and implications for patients with lung carcinoma.
    Sanlioglu AD; Aydin C; Bozcuk H; Terzioglu E; Sanlioglu S
    Lung Cancer; 2004 May; 44(2):199-211. PubMed ID: 15084385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.